Results 91 to 100 of about 4,810 (156)

Case Report: Nephrocalcinosis from pancreatic hypoplasia in HNF1B disease: a multigenerational expression with genetic confirmation in the youngest generation. [PDF]

Front Med (Lausanne)
Gopireddy NSR, Grover S, Khawaja I, Mudarres MF, Rastogi P, Story M, Thomas CP.   +6 more
europepmc   +1 more source

Primary hyperoxaluria: insights into its clinical presentation, genetic mutations, and transplantation outcomes in a pediatric population in a tertiary care center. [PDF]

Orphanet J Rare Dis
Sayed B, Alhuthil R, Saadeh S, Al-Shareef T, Alhassoun I, Al-Sabban E.   +5 more
europepmc   +1 more source

Real-world burden of primary hyperoxaluria with chronic kidney disease in the United States: a retrospective administrative claims analysis. [PDF]

BMC Nephrol
Goldfarb DS, Modersitzki F, Skaar JR, Li O, Salem S, Chen JV.   +5 more
europepmc   +1 more source

Kidney Stone Events and ESKD Incidence in Patients with Enteric Hyperoxaluria from Diverse Enteric Etiologies. [PDF]

Kidney360
Tatton RW, O'Neill SR, Jordan D, Vaughan LE, Lieske JC, Keddis MT.   +5 more
europepmc   +1 more source

Tailored Kidney Stone Prevention Improves Metabolic Risk Factors and Reduces Renal Colic Rate. [PDF]

Kidney Int Rep
Van de Perre E, Janssens FV, De Clerck D, Cools W, Janssens P, Allamani M, Robberechts T, Van Hulle F, Pipeleers L, François K, Bazin D, Tielemans C, Daudon M, Letavernier E, Wissing KM.   +14 more
europepmc   +1 more source

Re: Pierre Letourneau, Lara Cabezas, Aurélie De Mul, et al. Optimizing Screening Performance for the Risk of Hyperoxaluria and Urolithiasis Using the Urinary Oxalate/Creatinine Ratio: A Retrospective Analysis. Eur Urol Open Sci 2025;75:20-8. [PDF]

Eur Urol Open Sci
Liu D, Guan Z, Du Y.
europepmc   +1 more source

First retrospective study on pediatric nephrocalcinosis in Syria: clinical symptoms and causes. [PDF]

Front Pediatr
Ghanem H, Hassan M, Swideah S, Wannous H.   +3 more
europepmc   +1 more source

Primary hyperoxaluria [PDF]

Pediatrie pro praxi, 2016
openaire   +1 more source

Lumasiran at birth changes the trajectory of primary hyperoxaluria type 1: same disease, different outcomes in two affected siblings. [PDF]

J Nephrol
Peruzzi L, Leporati M, Pediatric Oxal Turin Working Group.   +2 more
europepmc   +1 more source

Enteric Hyperoxaluria [PDF]

, 2020
openaire   +1 more source